PrEP dosing for women is an activist issue, threats from America First, HIV and sleep…

1 January 2026. Related: News.

January news – December news – November news – All back issues

Recent HTB highlights

Event-based PrEP dosing for women: a challenge to guidelines and an activist issue

Two recent studies looking to explain how PrEP works suggest easier dosing might be possible for women and transgender and non-binary people or when the risk is from shared injecting rather than from sex. This special report looks at the differences between PrEP guidelines and why this is an activist issue in 2026.

Achieving HIV viral suppression and reducing stimulant use in San Francisco pilot programme

An innovative incentive-based pilot programme that increased viral suppression from 55% to 88% over 12 weeks.

Cancer and women living with HIV: results from D:A:D and RESPOND support including screening in routine HIV care

This large international observational collaboration involving over 17,000 women living with HIV report the risks of cancers and highlights factors to help with earlier diagnosis.

Confirmed safety of kidney transplant when both recipient and donor are HIV positive

US study reporting similar safety and efficacy for HIV positive transplant recipients irrespective of the HIV status of the donor.

Neutralising antibodies wane two years after mpox infection or vaccination: protection persists

This Italian study reports on the duration of neutralisiing antibody responses two years after mpox infection or vaccination.

All reports

Subscribe to HTB by email to receive the latest news every 3-4 weeks.

Reports will also be posted to social media.

Twitter (X) – Bluesky – Facebook – Instagram